Drug-eluting beads transarterial chemoembolization improves tumor response and survival compared with conventional TACE in intermediate-stage hepatocellular carcinoma: a retrospective cohort study
American Journal of Cancer Research · 2026 · 16 (5) · 2080-2092
DOI: 10.62347/cqxn5763 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Guiwen Shao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Therapy, The First Affiliated Hospital of Dalian Medical University Dalian 116011, Liaoning, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Therapy, The First Affiliated Hospital of Dalian Medical University Dalian 116011, Liaoning, China.
Zitieren
APA
Shao, G., & Liu, J. (2026). Drug-eluting beads transarterial chemoembolization improves tumor response and survival compared with conventional TACE in intermediate-stage hepatocellular carcinoma: a retrospective cohort study. American Journal of Cancer Research, 16(5), 2080-2092. https://doi.org/10.62347/cqxn5763
Vancouver
Shao G, Liu J. Drug-eluting beads transarterial chemoembolization improves tumor response and survival compared with conventional TACE in intermediate-stage hepatocellular carcinoma: a retrospective cohort study. American Journal of Cancer Research. 2026;16(5):2080-2092. doi:10.62347/cqxn5763
BibTeX
@article{Shao2026,
author = {Shao, Guiwen and Liu, Jianfei},
title = {Drug-eluting beads transarterial chemoembolization improves tumor response and survival compared with conventional TACE in intermediate-stage hepatocellular carcinoma: a retrospective cohort study},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {5},
pages = {2080--2092},
doi = {10.62347/cqxn5763}
}
EUVIMED